Research Paper Volume 13, Issue 6 pp 8355—8368
90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro
Figure 3. Correlation of 90K expression with dendritic cell-specific marker genes in CGGA and TCGA datasets. Each circle represents a patient with glioma.